Deep Brain Stimulation II: Advanced Management in Movement Disorders and Applications Beyond Movement Disorders
Sunday April 23, 2017 3:30 pm to 5:30 pm
Jill Ostrem MD
Deep brain stimulation is widely used to treat advanced, medication-resistant movement disorders, including essential tremor, Parkinson's disease, and dystonia. An understanding of the DBS device, proper patient selection, and optimized postoperative management is essential to achieve successful outcomes with DBS, maximize patient benefits, and minimize adverse effects or complications. Each of these key issues will be discussed, with an emphasis on practical information for the clinician. This course has been divided into two sequential sessions, and those registering for the course are encouraged to participate in both Part I and Part II for a comprehensive overview of the topic. Part I will focus on patient candidacy and basic programming in movement disorders. Part II will cover more advanced DBS in movement disorders and evolving DBS indications beyond movement disorders. The program will include case-based discussion.
This program complements C35: Deep Brain Stimulation Management I: Basic Principles and Programming in Movement Disorders, but covers independent topics.
Participants should be able to describe the rationale for the use of DBS and the patients for whom the treatment is most indicated, and have a general understanding and appreciate the principles of DBS programming, advanced patient management, and novel DBS indications.
Medical Knowledge, Patient Care
Program Speakers - Tentative
3:30 PM - 3:35 PM
Jill L. Ostrem MD
3:35 PM - 4:05 PM
Advanced Management of PD, ET, Dystonia, and Troubleshooting
Joohi Jimenez Shahed MD
4:05 PM - 4:35 PM
Novel and Emerging Uses of DBS: OCD, Tourette Syndrome, Depression, Alzheimer's, and Epilepsy
Michael S. Okun MD, FAAN
5:05 PM - 5:30 PM
Joohi Jimenez Shahed, MD
Dr. Jimenez Shahed has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with St. Jude Medical/Abbott, Medtronic, Teva, and Bracket. Dr. Jimenez Shahed has received research support from Biotie, Medtronic, and St. Jude Medical/Abbott.
Michael S. Okun, MD, FAAN
Dr. Okun has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with National Parkinson Foundation, Medscape, and Mededicus. Dr. Okun has received personal compensation in an editorial capacity for New England Journal of Medicine Journal Watch, and JAMA Neurology.
Jill L. Ostrem, MD
Dr. Ostrem has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Neurocrine and Adamas.